Conversation With
Latest
Conversation With: John Olajide of Axxess
The Axxess founder and CEO participated in the African Business Summit this summer to develop business relationships between the continent and American corporations.
Commercial Real Estate
Conversation With: Arcilia Acosta of CARCON Industries
The CEO, who also founded STL Engineers and is current chair of the Dallas Citizens Council, talks about her new headquarters, projects she has in the works, and more.
Conversation With: Scott Flannery
The United Healthcare of Texas CEO discusses price transparency, the transition to value-based care, and the impact of new legislation.
On the Links With: Tré Black, CEO of On-Target Supplies & Logistics
The logistics CEO—and Baylor University Medical Center board member—talks On-Target's 300 percent EBITDA growth in 2022, establishing On-Target as a holding company, and a prospective campaign that will transform BUMC.
Conversation With: Dr. Jason Tibbels
The Decatur family physician and Teladoc Health chief quality officer discusses the future of telehealth and how Teladoc is leading the way in patient safety.
Latest
Conversation With: Jason Villalba
The partner at Frost Brown Todd talks plans for launching the Texas presence of CivicPoint, a government relations subsidiary of the law firm, deal volume trends for 2023, and more.
Conversation With: Jeff Carcara, Sixty Vines
The leader of three brands under parent company FB Society, including wine-and sustainability-centered Sixty Vines, shares his plans for growth, goals for reducing food waste, and more.
Conversation With: Jennifer Cowley
The UTA president shares details about her career path and plans for the future of the university.
Conversation With: Tiffany Woodson, Ink + Oro
The interior design exec explains the reason for her company's name and what's hot in multifamily design.
On the Links With: Jeff Fehlis, American Cancer Society
Over a round of golf at Cowboys Golf Club, the executive vice president of the south region for American Cancer Society talks about how ACS is advancing cancer research, reducing treatment barriers, fundraising efforts, and more.